Health Innovation: No Citizen Left Behind

• Life Sciences
• CRA Insights

MFN is rewriting the launch planning playbook: Commercial and market access strategies must integrate to succeed

MFN-related uncertainty is reshaping pharmaceutical launch planning by making pricing, sequencing, and forecasting decisions more interconnected and...

• Life Sciences
• Reports

Ending the HIV epidemic: Ensuring equitable access to innovative HIV treatment and care

While advances in prevention, testing, and treatment have transformed outcomes for many people living with or at risk of HIV, significant inequities continue...

• Damages & Quantum
• Sponsorship & Speaking Engagement

• September 15-16, 2026
• Boston, MA

Pharma & Biotech Patent Litigation Summit North America 2026

CRA is a proud sponsor of the conference. Greg Bell speaks during the session titled “Damages in Pharma & Biotech Litigation:  What Courts are Accepting...